Xiaolan Bian - Concepedia

Author

Xiaolan Bian

Also Known As

Bian X, Bian Xiaolan, X Bian, X. Bian, Xiao-Lan Bian, Xiaolan BIAN, Xiaolan Bian, Xiao‐Lan Bian, Xiao‐lan Bian, Xin-Fang Bian

Publications

497

Citations

H-Index

Concepts

All Affiliations

Ruijin Hospital Shanghai Jiao Tong University Shanghai Chest Hospital Shanghai University of Traditional Chinese Medicine Fudan University

About

Xiaolan Bian is an author at Ruijin Hospital specializing in drug discovery, medicine, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	64
2	Biostatistics	1	1	64
3	Hepatology	1	1	64
4	Pharmacology	1	1	64
5	Drug Discovery	1	1	64

Xiaolan Bian

Publications

426

Citations

H-Index

Page 1

	Year	Citations
Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling Size Li, Yiqun Yu, Xiaolan Bian, Archives of Toxicology Traditional Chinese MedicinesHepatologyPredictive ToxicologyForensic ToxicologyPharmacology	2021	64
Ceftazidime-Avibactam in Combination with In Vitro Non-susceptible Antimicrobials Versus Ceftazidime-Avibactam in Monotherapy in Critically Ill Patients with Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective Cohort Study Guanhao Zheng, Jianxin Zhang, Bei Wang, Infectious Diseases and Therapy	2021	44
LncRNA TDRG1-Mediated Overexpression of VEGF Aggravated Retinal Microvascular Endothelial Cell Dysfunction in Diabetic Retinopathy Qiaoyun Gong, Wenpei Dong, Ying Fan, Frontiers in Pharmacology	2020	43
Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study Jie Fang, Hui Li, Min Zhang, Frontiers in Pharmacology	2021	35
Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study Guanhao Zheng, Jiaqi Cai, Liang Zhang, Infectious Diseases and Therapy	2022	30
Vitamin C reduces vancomycin-related nephrotoxicity through the inhibition of oxidative stress, apoptosis, and inflammation in mice Juan He, Wenyun Xu, Xiaoxiao Zheng, Annals of Translational Medicine	2021	29
Does the conventional dosage of linezolid necessitate therapeutic drug monitoring?—Experience from a prospective observational study Jie Fang, Congqin Chen, Yan Wu, Annals of Translational Medicine	2020	26
A higher dose of vancomycin is needed in critically ill patients with augmented renal clearance Juan He, Zhitao Yang, Xian Qian, Translational Andrology and Urology	2020	21
Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma Ping Yu, Wenpei Dong, Ya‐Bin Tang, Annals of Translational Medicine	2021	16
Model Based Identification of Linezolid Exposure–toxicity Thresholds in Hospitalized Patients Jie Fang, Xiaoshan Zhang, Chunhong Zhang, Frontiers in Pharmacology	2021	15

Page 1